{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:02:06Z","timestamp":1789848126233,"version":"4.0.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82502833"],"award-info":[{"award-number":["82502833"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.cca.2026.121331","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:21:24Z","timestamp":1789086084000},"page":"121331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Site-specific glycosylation of serum antithrombin-III as a potential biomarker for AFP-negative HCC"],"prefix":"10.1016","volume":"594","author":[{"given":"Xinyi","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoquan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2026.121331_bb0005","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3350\/cmh.2022.0402","article-title":"Clinical practice guidelines and real-life practice in hepatocellular carcinoma: a Chinese perspective","volume":"29","author":"Xie","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.cca.2026.121331_bb0010","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2026.121331_bb0015","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.annonc.2025.02.006","article-title":"Hepatocellular carcinoma: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"36","author":"Vogel","year":"2025","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cca.2026.121331_bb0020","article-title":"Analysis of serum Paraoxonase 1 using mass spectrometry and lectin immunoassay in patients with alpha-fetoprotein negative hepatocellular carcinoma","volume":"11","author":"Cao","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cca.2026.121331_bb0025","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12876-022-02279-w","article-title":"A comparison of clinical pathologic characteristics between alpha-fetoprotein negative and positive hepatocellular carcinoma patients from eastern and southern China","volume":"22","author":"Chi","year":"2022","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.cca.2026.121331_bb0030","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.3390\/ijms24054286","article-title":"Updating the clinical application of blood biomarkers and their algorithms in the diagnosis and surveillance of hepatocellular carcinoma: a critical review","volume":"24","author":"Shahini","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2026.121331_bb0035","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL clinical practice guidelines on the management of hepatocellular carcinoma","volume":"82","author":"Sangro","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cca.2026.121331_bb0040","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41392-024-01886-1","article-title":"Glycosylation: mechanisms, biological functions and clinical implications","volume":"9","author":"He","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cca.2026.121331_bb0045","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/cac2.12610","article-title":"Altered glycosylation in cancer: molecular functions and therapeutic potential","volume":"44","author":"Xu","year":"2024","journal-title":"Cancer Commun."},{"key":"10.1016\/j.cca.2026.121331_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2024.343066","article-title":"Benchmark N-glycoproteomics study of common differential tissue and serum N-glycoproteins of patients with hepatocellular carcinoma","volume":"1322","author":"Bi","year":"2024","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.cca.2026.121331_bb0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/mas.21583","article-title":"Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches","volume":"38","author":"Zhu","year":"2019","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.cca.2026.121331_bb0060","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1074\/mcp.RA119.001722","article-title":"N-glycopeptide signatures of IgA2 in serum from patients with hepatitis B virus-related liver diseases","volume":"18","author":"Zhang","year":"2019","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.cca.2026.121331_bb0065","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1021\/ac404246w","article-title":"pQuant improves quantitation by keeping out interfering signals and evaluating the accuracy of calculated ratios","volume":"86","author":"Liu","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.cca.2026.121331_bb0070","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac261","article-title":"Hiplot: a comprehensive and easy-to-use web service for boosting publication-ready biomedical data visualization","volume":"23","author":"Li","year":"2022","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.cca.2026.121331_bb0075","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v31.i23.107100","article-title":"Hepatocellular carcinoma in patients without cirrhosis","volume":"31","author":"Sato-Espinoza","year":"2025","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cca.2026.121331_bb0080","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3350\/cmh.2022.0212","article-title":"Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region","volume":"29","author":"Kim","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.cca.2026.121331_bb0085","doi-asserted-by":"crossref","first-page":"7732","DOI":"10.3390\/ijms24097732","article-title":"Plasma antithrombin III levels can be a prognostic factor in liver cirrhosis patients with portal vein thrombosis","volume":"24","author":"Suda","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2026.121331_bb0090","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1182\/blood.2021014708","article-title":"Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays","volume":"140","author":"De La Morena-Barrio","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.cca.2026.121331_bb0095","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-024-01532-x","article-title":"Decoding the glycoproteome: a new frontier for biomarker discovery in cancer","volume":"17","author":"He","year":"2024","journal-title":"J. Hematol. Oncol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126005139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126005139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:18:51Z","timestamp":1789845531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126005139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":19,"alternative-id":["S0009898126005139"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121331","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Site-specific glycosylation of serum antithrombin-III as a potential biomarker for AFP-negative HCC","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121331","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121331"}}